Citation: | ZHAO Juanzhi, WANG Cong, LI Jindian, ZHANG Dongjian, ZHANG Jian, YIN Zhiqi. Metabolites of hypericin in rats in vivo[J]. Journal of China Pharmaceutical University, 2016, 47(4): 457-462. DOI: 10.11665/j.issn.1000-5048.20160411 |
[1] |
Cooper EH, Bedford AJ, Kenny TE. Cell death in normal and malignant tissues[J].Adv Cancer Res,1975,21:59-120.
|
[2] |
Smith BA,Smith BD.Biomarkers and molecular probes for cell death imaging and targeted therapeutics[J].Bioconjug Chem,2012,23(10):1989-2006.
|
[3] |
Chen SL, Yu LK, Jiang CY, et al. Pivotal study of iodine-131-labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer[J].J Clin Oncol,2005,23(7):1538-1547.
|
[4] |
Li J, Oyen R, Verbruggen A, et al. Small molecule sequential dual-targeting theragnosticstrategy(SMSDTTS):from preclinical experiments towards possible clinical anticancer applications[J].J Cancer,2013,4(2):133-145.
|
[5] |
Van de Putte M,Marysael T,Fonge H,et al.Radiolabelediodohypericin as tumor necrosis avid tracer:diagnostic and therapeutic potential[J].Int J Cancer,2012,131(2):E129-E137.
|
[6] |
Kerb R,Brockmller J,Staffeldt B,et al.Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin[J].Antimicrob Agents Chemother,1996,40(9):2087-2093.
|
[7] |
Kamuhabwa AAR,Di Mavungu JD,Baert L,et al.Determination of hypericin in human plasma by high-performance liquid chromatography after intravesical administration in patients with transitional cell carcinoma of the bladder[J].Eur J Pharm Biopharm,2005,59(3):469-474.
|
[8] |
Kong M,Zhang J,Jiang CH,et al.Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis[J].J Drug Target,2013,21(6):604-610.
|
[9] |
Yan YT,LaiChang JS,Li P,et al.Metabolites of salvianolic acid C in rats[J].J China Pharm Univ (中国药科大学学报),2013,44(5):442-446.
|
[10] |
Zhang YQ, Long T, Niu YJ, et al. Research progress in oral absorption and metabolism of natural anthraquinones[J].Strait Pharm J (海峡药学),2014,26(7):1-5.
|
[11] |
Song R,Xu L,Xu FG,et al.Metabolic analysis of rhubarb extract by rat intestinal bacteria using liquid chromatography-tandem mass spectrometry[J].Biomed Chromatogr,2011,25(3):417-426.
|
[12] |
Song R,Lin H,Zhang ZJ,et al.Profiling the metabolic differences of anthraquinone derivatives using liquid chromatography/tandem mass spectrometry with data-dependent acquisition[J].Rapid Commun Mass Spectrom,2009,23(4):537-547.
|
[13] |
Song R,Xu FG,Zhang ZJ,et al.Structural elucidation of in vitro metabolites of emodin by liquid chromatography-tandem mass spectrometry[J].Biomed Chromatogr,2008,22(11):1230-1236.
|
[14] |
Liu W,Zheng ZJ,Liu X,et al.Sensitive and robust UPLC-MS/MS method to determine the gender-dependent pharmacokinetics in rats of emodin and its glucuronide[J].J Pharm Biomed Anal,2011,54(5):1157-1162.
|
[15] |
Wan JB,Bai X,Cai XJ,et al.Chemical differentiation of Da-Cheng-Qi-Tang,a Chinese medicine formula,prepared by traditional and modern decoction methods using UPLC/Q-TOFMS-based metabolomics approach[J].J Pharmaceut Biomed Analy,2013,83:34-42.
|
[16] |
Bánó G,Staniová J,Jancura D,et al.On the diffusion of hypericin in dimethylsulfoxide/water mixtures—the effect of aggregation[J].J Phys Chem B,2011,115(10):2417-2423.
|
[17] |
Liu XJ,Jiang CH,Li Y,et al.Evaluation of hypericin:effect of aggregation on targeting biodistribution[J].J Pharm Sci,2015,104(1):215-222.
|
[18] |
Yang J,Qian DW,Duan JA,et al.Advances in studies on metabolism of constituents in Chinese materiamedica by intestinal bacteria[J].Chin Tradit Herb Drugs (中草药),2011,42(11):2335-2344.
|
[1] | TU Penghuang, YAO Zhiren, JIN Meiling, NING Guanyu, HUANG Yaping, PAN Ke, YIN Zhiqi. Study of glycosides from Piper sintenense Hatusima[J]. Journal of China Pharmaceutical University, 2024, 55(2): 202-208. DOI: 10.11665/j.issn.1000-5048.2023122704 |
[2] | CAI Caihong, ZHENG Hao, GAI Cuijuan, DAI Haofu, MEI Wenli, CHEN Huiqin. Secondary metabolites of the endophytic fungus Aspergillus sp.Dq-25 from barnacle[J]. Journal of China Pharmaceutical University, 2023, 54(1): 62-67. DOI: 10.11665/j.issn.1000-5048.20220531001 |
[3] | FANG Siyang, ZHANG Xinggui, YE Yu, WANG Keqing, YAO Zhiren, HUANG Yaping, ZHANG Jian, QIN Yanhua, YIN Zhiqi. A new ester glycoside compound from Cyclocarya paliurus[J]. Journal of China Pharmaceutical University, 2023, 54(1): 56-61. DOI: 10.11665/j.issn.1000-5048.20221209002 |
[4] | XIE Jing, FAN Chunlin, XU Jie, ZHANG Jian, YE Wencai, ZHANG Xiaoqi. Alkaloids of Ervatamia pandacaqui[J]. Journal of China Pharmaceutical University, 2021, 52(3): 287-292. DOI: 10.11665/j.issn.1000-5048.20210304 |
[5] | ZHANG Yilun, ZHAO Xinyi, DONG Shubo, DONG Chao, SHEN Wenbin, DONG Haijuan. Isolation and identification of unknown impurities of alogliptin benzoate[J]. Journal of China Pharmaceutical University, 2020, 51(4): 488-493. DOI: 10.11665/j.issn.1000-5048.20200415 |
[6] | TAO Junjie, YANG Jie, WEN Xiaodong. Studies on the chemical constituents in the aerial parts of Paris polyphylla var. Yunnanensis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 454-460. DOI: 10.11665/j.issn.1000-5048.20200410 |
[7] | HUANG Qilong, ZHANG Wanjin, LI Yan, CHEN Juan, ZHOU Baoping, ZOU Xiaohan, ZHANG Chunlei, CAO Zhengyu. Alkaloid constituents from Corydalis decumbens[J]. Journal of China Pharmaceutical University, 2017, 48(5): 563-567. DOI: 10.11665/j.issn.1000-5048.20170509 |
[8] | WANG Jingyi, DONG Yangyang, QI Chulu, ZHANG Jiayao, ZHANG Minjie, WANG Hao. Chemical constituents of the stem bark of Bombax ceiba L.[J]. Journal of China Pharmaceutical University, 2016, 47(5): 570-574. DOI: 10.11665/j.issn.1000-5048.20160511 |
[9] | YANG Hanbing, YANG Wenqiang, SONG Min, ZHANG Jian, ZHANG Xiaoqi, YE Wencai. Phenolic constituents of Galla Chinensis and their antiviral activities[J]. Journal of China Pharmaceutical University, 2016, 47(5): 566-569. DOI: 10.11665/j.issn.1000-5048.20160510 |
[10] | Isolation and Identification of Two Taxane DiterpenoidCompounds[J]. Journal of China Pharmaceutical University, 2001, (3): 32-34. |